Requested Daily News Article

On the Development of Sirtuin Activators (Tuesday January 09 2007) Chris Patil notes a number of recent papers on progress towards the commercial deployment of sirtuin activators - calorie restriction mimetics, in other words - and ostacles yet in the way: "Given the current regulatory laws in the US and elsewhere, getting drugs approved as anti-aging therapies per se is difficult to say the least, approaching the level of practical impossibility. Beyond the political and sociological challenges of defining aging as a pathology in itself are a huge number of nuts-and-bolts issues: How does one measure successful delays in aging? How does one define a Phase I (or II, or III) population, and secure subject compliance over the relevant timescales? But suppose compounds with anti-aging properties (to be more precise, I should say, 'compounds that target pathways known to modulate lifespan in experimental organisms') are approved for clinical treatment of acute or shorter-term chronic diseases, where the trial populations and standards for efficacy are easier to define. We'd then have anti-aging drugs ready for off-label use after they've been proven effective for their on-label purpose." Link to original article   Share |

Prior News Machinery Will Make Us Long-Lived and Utterly Healthy Ever More Capable Nanoparticles Geriatrics, Gerontology and Engineering Nanobiotechnology at the NYAS Essay Contest: Why Are People So Hateful About CR?

Later News Another Key To Calorie Restriction Biochemistry A Little Biochemistry of "Use It Or Lose It" Update on Telomere Length and Heart Disease More on Calorie Restriction and the Immune System The Third SENS Conference

We help you stay up to date with the most interesting news in medicine, politics and the healthy life extension community. You can help us by contacting us when you see interesting items online. You can search past news postings through Google by using the form to the right.

Search Past News     Search